Article info
PDFCorrespondence
Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials
- Correspondence to Professor Young Ho Lee, Rheumatology, Korea University, Seoul 02841, Korea; lyhcgh{at}korea.ac.kr
Citation
Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials
Publication history
- Received May 31, 2019
- Accepted June 2, 2019
- First published June 11, 2019.
Online issue publication
September 14, 2020
Article Versions
- Previous version (11 June 2019).
- Previous version (14 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.